David Vitter

Vitter, Breitbart Revive Death Panel Smear In Attack On FDA Breast Cancer Drug Decision

Brian Beutler | July 28, 2010, 1:29PM

Senator David Vitter (R-LA)

In one fell swoop today, Sen. David Vitter (R-LA) revived the specter of health care death panels, and called into question the FDA's ability to judge the effectiveness of breast cancer medication.

According to the Associated Press, Vitter slammed the FDA, which voted 12-1 to drop its endorsement of the breast cancer drug Avastin after research showed that its additional positive effects were minimal, but it was associated with increased liver toxicity. Vitter called the decision "sickening" -- but not because the FDA's accelerated approval of the drug in 2007 went against the medical advise of its advisory committee or because women with metastatic breast cancer using the drug were more likely to die. Instead, he compared the FDA's reversal to withholding care for patients whose lives are "not deemed valuable enough."

Read more »